ANIX (Anixa Biosciences) FFO


ANIX Anixa Biosciences Inc ANIX
27 GF Score
Price $2.40
! 3 Warning Signs
View Full Analysis

What is Anixa Biosciences FFO?

FFO (Funds from operations) only applies to REITs.

ANIX
27GF Score
Anixa Biosciences Inc ANIX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anixa Biosciences Business Description

Other Exchanges CY71:Germany
Address 3150 Almaden Expressway, Suite 250, San Jose, CA, USA, 95118
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
27GF Score

Get the complete analysis for ANIX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.40
Price